St. Anna Kinderkrebsforschung
🇦🇹Austria
- Country
- 🇦🇹Austria
- Ownership
- -
- Established
- 1986-01-01
- Employees
- -
- Market Cap
- -
ALL-SCT BFM International- HSCT in Children and Adolescents With ALL
Phase 3
- Conditions
- Lymphoblastic Leukemia, Acute, Childhood;
- Interventions
- First Posted Date
- 2011-08-26
- Last Posted Date
- 2015-06-26
- Lead Sponsor
- St. Anna Kinderkrebsforschung
- Target Recruit Count
- 405
- Registration Number
- NCT01423500
- Locations
- 🇫🇷
Pediatric Immuno-Hematology Unit Robert Debré Hospital, Paris, France
🇳🇱Leiden University Hospital, Leiden, Netherlands
🇸🇪Department of Pediatric Oncology, Lund University Hospital, Lund, Sweden
Interleukin-2 in Treating Children With Stage IV Neuroblastoma Who Have Received Induction Therapy and Peripheral Stem Cell Transplantation
Phase 2
- Conditions
- Neuroblastoma
- First Posted Date
- 2004-07-16
- Last Posted Date
- 2013-09-17
- Lead Sponsor
- St. Anna Kinderkrebsforschung
- Target Recruit Count
- 25
- Registration Number
- NCT00003743
- Locations
- 🇦🇹
St. Anna Children's Hospital, Vienna, Austria
© Copyright 2025. All Rights Reserved by MedPath